LIXT Lixte Biotechnology Holdings, Inc.
Healthcare$5.88-0.51%ClosedMarket Cap: $72.8M
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
6
Dispositions
6
Buy/Sell Ratio
1.00
Net Shares
+0
Shares Acquired
500,000
Shares Disposed
500,000
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Apr 17 | Stazzone Peter | officer: Chief Financial Officer | Sell | 50,000 | $4.45 | 0 |
| Fri Apr 17 | Stazzone Peter | officer: Chief Financial Officer | Sell | 50,000 | $0.00 | 50,000 |
| Fri Apr 17 | Sawyer Jason David | director | Sell | 25,000 | $3.59 | 0 |
| Fri Apr 17 | Sawyer Jason David | director | Sell | 25,000 | $0.00 | 25,000 |
| Fri Apr 17 | Pursglove Geordan Garrett | director, officer: CEO and Chairman of the Board | Sell | 350,000 | $2.83 | 0 |
| Fri Apr 17 | Pursglove Geordan Garrett | director, officer: CEO and Chairman of the Board | Sell | 350,000 | $0.00 | 350,000 |
| Fri Apr 17 | Primus Guy Warren | director | Sell | 25,000 | $0.00 | 25,000 |
| Fri Apr 17 | Holloway Michael Andrew | director | Sell | 25,000 | $0.00 | 25,000 |
| Fri Apr 17 | Felix Lourdes | director | Sell | 25,000 | $4.05 | 0 |
| Fri Apr 17 | Felix Lourdes | director | Sell | 25,000 | $0.00 | 25,000 |
| Mon Dec 29 | Primus Guy Warren | director | Sell | 25,000 | $4.05 | 25,000 |
| Mon Dec 29 | Felix Lourdes | director | Sell | 25,000 | $4.05 | 25,000 |
| Wed Sep 10 | Primus Guy Warren | director: | Sell | 0 | $0.00 | 0 |
| Thu Sep 04 | Stazzone Peter | officer: Chief Financial Officer | Sell | 50,000 | $4.45 | 50,000 |
| Thu Sep 04 | Stazzone Peter | officer | Sell | 0 | $0.00 | 0 |